Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: a pooled analysis of four placebo-controlled trials with long-term extensions - Ashina, M; Kudrow, D; Reuter, U; Dolezil, D; Silberstein, S; Tepper, SJ (Cephalalgia, 2019)